ICON Plc (ICLR) Market Cap: $1.96 billion ICLR is a Contract Research Organization. These organizations are essential to the pharmaceutical industry as they handle the time consuming and messy process of managing the clinical trials necessary for the approval of new medicines. The largest player in the industry is privately held Quintiles, but among the public companies, ICLR appears best positioned for a long, steady climb. ICLR has demonstrated robust growth, with revenue rising from $297 million in 2003 to $1,115 million in 2012, an increase of 275%. ICLR has a global presence and offers laboratory services as well, meaning that they can do just about everything for their clients except create new molecules. We see ICLR as a buy and hold opportunity.
Market Data 
Markets 
AI
